About Polytherics
Polytherics is a company based in Cambridge (United Kingdom) founded in 2002. Polytherics has raised $12.56 million across 5 funding rounds from investors including Mercia, YFM Equity Partners and Invesco Perpetual. Polytherics has completed 1 acquisition, including Warwick Effect Polymers. Polytherics offers products and services including Antibody Discovery, Cell Line Development, Bioconjugate Development, and Analytics and Bioassays. Polytherics operates in a competitive market with competitors including KBI Biopharma, EirGenix, Aldevron, Arranta Bio and Ovagen, among others.
- Headquarter Cambridge, United Kingdom
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Abzena Limited
- Date of Incorporation 25 Mar, 2014
- Jurisdiction CAMBRIDGE
-
Annual Revenue
$2.62 M (USD)109as on Dec 31, 2016
-
Net Profit
$363.26 K (USD)-42as on Dec 31, 2016
-
EBITDA
Not available
-
Total Equity Funding
$12.56 M (USD)
in 5 rounds
-
Latest Funding Round
Not available
-
Investors
Mercia
& 5 more
-
Employee Count
Not available
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Polytherics
Polytherics offers a comprehensive portfolio of products and services, including Antibody Discovery, Cell Line Development, Bioconjugate Development, and Analytics and Bioassays.
Service for developing high-affinity antibodies with desired activity.
Generates cell lines for biologics production and GMP compliance.
Designs and develops ADCs, AOCs, and RDCs for drug advancement.
Performs method development and assays for biologic characterization.
Funding Insights of Polytherics
Polytherics has successfully raised a total of $12.56M across 5 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Polytherics
Polytherics has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Mercia, YFM Equity Partners and Invesco Perpetual.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments in startups are focused on Europe and the US.
|
Locked | Locked | Locked | |
|
Private equity firm focused on multiple sectors
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Polytherics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Polytherics
Polytherics has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Warwick Effect Polymers.
Investment portfolio details for Polytherics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Complex polymers are manufactured via living controlled radical polymerization.
|
Locked | Locked | 2001 | Locked |
Complete acquisition details for Polytherics
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Polytherics
Detailed financials for Polytherics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Polytherics Comparisons
Peer comparison for Polytherics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Polytherics
Polytherics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as KBI Biopharma, EirGenix, Aldevron, Arranta Bio and Ovagen, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of protein formulation, process & cell line development, and cGMP services
|
|
| Locked | Locked | Locked |
Biologics development and manufacturing services are offered by EirGenix.
|
|
| Locked | Locked | Locked |
Developer and custom manufacturer of nucleic acids, proteins and antibodies for research, clinical and commercial applications
|
|
| Locked | Locked | Locked |
Developer of therapeutics for microbiome based diseases
|
|
| Locked | Locked | Locked |
Provider of germ-free and specific pathogen free production of eggs for vaccine and antibody manufacturing services
|
|
| Locked | Locked | Locked |
Vaccines and biologics are developed and manufactured by IDT Biologika.
|
Detailed competitors of Polytherics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Polytherics
Complete news archive for Polytherics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Polytherics
Polytherics was founded in 2002 and raised its 1st funding round 5 years after it was founded.
Polytherics is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.
Polytherics is a funded company, having raised a total of $12.56M across 5 funding rounds to date.
Annual revenue of Polytherics is $2.62M as on Dec 31, 2016.
Polytherics was founded in 2002 in Cambridge, United Kingdom, as a developer of biomedical polymers and proprietary technologies for biopharmaceutical applications. Site-specific conjugation methods, including PEGylation and TheraPEG, were utilized for antibody-drug conjugates and protein-based drugs. A portfolio of products such as cytokines, antibodies, enzymes, hormones, peptides, and blood proteins was maintained. Services for immunogenicity assessment and protein engineering were integrated following a 2013 merger with Antitope to form Abzena.
Polytherics's top competitors include KBI Biopharma, Aldevron and Ovagen.
Polytherics offers Antibody Discovery, Cell Line Development, Bioconjugate Development, and Analytics and Bioassays.
Polytherics has made 1 acquisition, including Warwick Effect Polymers.
Polytherics has 6 investors. Key investors include Mercia, YFM Equity Partners, Invesco Perpetual, Imperial Innovations, and ProVen.